Lepu Biopharma Co. Ltd. Class H had a revenue of 461.10M in the quarter ending Dec 31, 2025, with -1.04%. This bring the company's revenue in the last twelve months to 927.05M, Decreased 32.35%. In the fiscal year ending Dec 31, 2025, Lepu Biopharma Co. Ltd. Class H had annual revenue of 910.67M with 147.60% growth.